FTSE 100 slips amid mixed corporate earnings, Diageo sinks

The FTSE 100 underperformed European peers in the early hours of trade on Tuesday but made a steady recovery after starting the session deep in the red.

Although investors are gearing up for a busy week of central bank action, a string of corporate updates yielding mixed results on Tuesday was the driving influence on shares on Tuesday

BP reported increased underlying replacement profit, Diageo sales and volumes sank, and Standard Chartered smashed analyst earnings estimates.

“With earnings season in full swing, there are several FTSE 100 names making big moves this morning on the back of their figures,” said Steve Clayton, head of equity funds, Hargreaves Lansdown.

“The headlines are that Diageo, Croda International and Sage Group are all heading south this morning after reporting results that left traders worrying about weak momentum in these stocks’ underlying revenues. On the leaderboard though, BP is up after hiking its quarterly dividend by 10%, whilst Standard Chartered released forecast-beating results and announced a further buy-back of stock.

The result was a 0.2% decline for the FTSE 100 at the time of writing.

Diageo

Diageo was the FTSE 100’s biggest detractor in terms of points on Tuesday, with the drinks giant slumping over 6% after confirming a net sales decline in the first half.

“A catastrophic session from Diageo served to drag down the FTSE 100 index,” said Russ Mould, investment director at AJ Bell.

Operating profits were higher during the period, but this did little to address concerns about the top line. Overall organic volumes were down 4% during the period.

“Diageo has gone from bad to worse,” Russ Mould said.

“It has reported an operating profit decline in four out of its five operating regions, two of them in substantial double-digit territory. The company can dress up the numbers all it wants, but it’s clear that something major has to change.

“Debra Crew will be fighting to keep her job as chief executive. If the board doesn’t do something, one can expect activist investors to circle Diageo and push for new leadership.”

Standard Chartered

There was a lot to like about Standard Chartered’s half-year report. Operating income was up 11% in the first half, and underlying profit before tax rose 21%. Shareholders are being rewarded with a bumper $1.5bn share buyback, which helped shares rise over 6% on Tuesday.

“We generated double-digit income growth, with positive momentum continuing into the second quarter, and with continued discipline in managing our expenses,” said Bill Winter, CEO of Standard Chartered.

“This led to a 20% growth in underlying profit before tax. Reflecting confidence in our performance and robust capital position, we are upgrading our guidance for income growth, which we now expect to be above 7% in 2024, and we are announcing our largest ever share buyback of $1.5bn.”

AIM movers: Jersey Oil and Gas tax uncertainty and Journeo upgrade

1

Shares in investment company Argo Group (LON: ARGO) jumped 50% to 6p following yesterday evening’s interim results announcement. Revenues more than tripled to $4.6m and pre-tax profit jumped from $100,000 to $2.5m. NAV was $7.3m at the end of June 2024.

Chemotherapy drug delivery technology developer CRISM Therapeutics (LON: CRTX) has won a service contract worth £230,000 with imphatec. This involves the formulation of synthetic hormones used to treat hormone deficiency illnesses. The work should be completed by the end of 2025. The share price is 18.5% higher at 16p.

Transport information and CCTV systems supplier Journeo (LON: JNEO) published a trading statement showing 17% higher interim revenues of £25.6m, while pre-tax profit jumped 54% to £2.8m. Net cash is £12.8m. Cavendish has raised its pre-tax profit estimate by 8% to £4.8m. Next year it is expected to increase to £5m. The share price increased by 12.5% to 256.5p.

Online gaming company Gaming Realms (LON: GMR) expects interim revenues to be m18% ahead at £13.5m and EBITDA should be 21% higher at £5.8m. Adding new partners has boosted income. Gaming Realms is on course to increase full year pre-tax profit from £5.4m to £8.8m. Net cash could double to £14m. The share price improved 4.84% to 39p.

FALLERS

North Sea-focused Jersey Oil and Gas (LON: JOG) could be hampered by the rise in the energy profits level to 38% and the main investment allowance of 29% will be removed from November. A reduction in capital allowances will be announced in the October Budget. The levy will be extended until 2030. The Great Buchan Area joint venture will be impacted. Jersey Oil and Gas has a full carry on much of the development spending of the project and there are potential milestone payments. However, the final investment decision could be hampered by the tax changes. The share price declined 16.1% to 73p.

FIH Group (LON: FIH) says the figures for the year to March 2024 will be in line with expectations of pre-tax profit of £3.5m, but there will be a shortfall this year. This is due to delays in tenders for the housing and construction business in the Falkland Islands. Zeus has withdrawn its estimates and valuation. The share price is 15.3% to 205p.

Promotional products services provider Altitude (LON: ALT) improved pre-tax profit by one-third to £1.2m in the year to March 2024. Zeus has increased its 2024-25 earnings forecast to 2.6p/share due to a lower than previously expected tax charge on pre-tax profit of £1.9m. That figure is the same as for 2023-24, where there was a tax credit. The share price dipped 10% to 40.5p.

Concrete levelling equipment supplier Somero Enterprises (LON: SOM) says poor weather conditions in North America and Australia have led to project delays. The second half should be stronger, but workforce reductions are underway. Cavendish has cut its 2024 pre-tax profit forecast by 13% to $27.6m and the dividend expectation has been slashed from 27.7 cents/share to 21.7 cents/share. There should still be cash of $27m at the end of 2024. The share price fell 8.57% to 320p.  

Creo Medical – First Half Trading Update Due Shortly Is Expected To Show Strong Positives 

Just over a year ago, 3rd August 2023, this £109m-capitalised group announced its First Half Trading Update, I am hoping that we will see it doing similarly within days. 

That could give private investors the chance to slip into a small position in the stock ahead of hoped-for positive news. 

Its shares, which were up to 50p at the end of 2023, are currently trading at only 30.25p. 

The Business 

The Chepstow-based Creo Medical (LON:CREO) is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy for pre-cancer and cancer patients.

Its declared mission is to improve patient outcomes by applying microwave and radiofrequency energy to surgical endoscopy. 

Procedures that previously took place in the operating room can now be undertaken in an endoscopy room, with material advantages in cost, time and patient outcomes. 

Using the group’s technology, initial health economic data has demonstrated that the NHS can save approximately £5,000 per procedure. 

Such Markets As 

It focuses on significant markets where it can bring products to market that serve poorly met needs.

Interventional gastroenterology – for the dissection, resection, ablation and haemostasis of diseased GI tissue. 

Interventional pulmonology – soft tissue Microwave ablation devices for ablation of tumours in a wide range of tissue types in the lung, stomach, oesophagus and colon. 

Surgery – its unique IP portfolio has a clear potential to meet needs in several additional lucrative markets in robotics and beyond. 

Urology – comprehensive line of Urodynamics equipment to treat conditions such as bladder cancer and incontinence. 

AGM Statement 

At the end of June, the group held its AGM at its offices in Chepstow, with the departing Chairman Charles Spicer stating that: 

The past 12 months have shown continued momentum in Creo’s journey towards becoming a mature, international medtech group. Using the financial resources provided by our March 2023 equity raise, we have continued to execute on all fronts of our strategy.  

This has included the launch of Speedboat UltraSlim, accelerated in the EU by 18 months, quickly being followed by the product being used in the US, APAC and Latin America, with exceptional clinician feedback. We have been delighted to see the investment in our Pioneer training programme continue to deliver a growing number of worldwide users, with a 119% increase over the course of 2023. 

The recent NHS Supply Chain data, which confirmed net cash savings of £687k from 130 Speedboat procedures at one NHS Trust, was a fantastic validation of the difference our technology can make to healthcare systems in addition to improving patient outcomes. We look forward to working alongside NHS Supply Chain as they promote the value proposition of Speedboat to Trusts around the country. 

The potential of Creo’s technology has also been demonstrated through our Kamaptive partnerships, as MicroBlate Flex was recently used to treat a cancerous lung nodule in the same sitting as a diagnosis performed with a robotic platform, in a world’s-first combined procedure at the Royal Brompton Hospital. 

The team has worked hard to keep disciplined control over costs, even as the business has continued to grow, which contributed to a reduced operating loss for the financial year ended 31 December 2023, and we continue to progress towards our goal of achieving cashflow break even in 2025.” 

The Equity And Significant Shareholders 

There are some 361.5m shares in issue. 

Larger holders include Canaccord Genuity (10.85%), M&G Investments (9.21%), Baillie Gifford (6.17%), Hargreaves Lansdown (4.95%), Amati Global Investors (4.70%), River Global Investors (4.42%), AXA Framlington Investment Managers (4.22%), Finance Wales Investments (3.98%), and Director Shareholdings (3.27%). 

Analyst Views 

Soo Romanoff and Jyoti Prakash, at Edison Investment Research, have estimates out for the current year to end-December, for revenues of £40.1m (£30.8m) helping to significantly reduce pre-tax losses to just £16.6m (£22.1m loss). 

For the coming year of 2025, they estimate £54.1m in sales and only a £4.8m loss. 

They conclude by noting that: 

“Robotics-assisted surgeries are widely regarded to be transformative for the healthcare system, given the ability for early cancer detection, greater surgical precision and shorter recovery times and we see this deal progression as an exciting opportunity for Creo to tap into this field.” 

Over at Cavendish Capital Markets, analyst Chris Donnellan stated that the group was at a significant inflection point in its development. 

His 2024 estimates are for £41.0m in revenues and only a £13.6m adjusted pre-tax loss. 

For 2025 he has £53.7m turnover and a £4.2m pre-tax loss. 

His Price Objective for Creo Medical’s shares is a significant 99p a share

In My View 

Just two months ago this group’s shares were trading at 36.50p, they are now only 30.25p – at which level risk-tolerant investors might do well taking a position now ahead of further positive news. 

Diageo shares plummet as sales and volumes decline

Diageo shares were sharply lower on Tuesday after the alcohol giant confirmed a poor year for sales in its preliminary results for the year ended 30th June.

Diageo has reported a 1.4% decline in net sales to $20.3 billion for the full-year period as sales in Latin America and the Caribbean region tanked. Poor sales translated to a 4% drop in organic volumes.

Despite these challenges, the company managed to boost its reported operating profit by 8.2%, with the operating profit margin expanding by 262 basis points. However, this did little to encourage investors and shares were down 8.5% at the time of writing on Tuesday.

The most significant factor contributing to Diageo’s struggles was a sharp 21.1% decline in sales within the Latin America and Caribbean (LAC) region. This precipitous drop in LAC overshadowed positive performance in other markets, resulting in an overall organic net sales decline of 0.6%. The company’s volume decreased by 3.5%, outweighing a 2.9 percentage point improvement in price and mix.

Excluding the LAC region, Diageo’s performance paints a different picture. Organic net sales outside LAC grew by 1.8%, driven by a robust 3.9 percentage point improvement in price and mix. This growth was partially offset by a 2.1% volume decline. Notably, while North America experienced a 2.5% decrease in organic net sales, this was more than compensated for by growth in Africa, Asia Pacific, and Europe.

“In what is perhaps a reality check from the pandemic boom for Diageo, they have posted their first yearly sales decline since 2020, which is in fact worse than analysts initially feared. A fancy bottle of whiskey for locked down consumers with a little extra cash in their pocket was the perfect treat at the time but now it seems that increased competition and price consciousness have hit Diageo’s bottom line,” said Adam Vettese, Market Analyst at eToro.

“The firm issued a profit warning due to inventory issues in the key Latin America region as well as loss of market share in the US. It is fair to say that times are tougher now, with consumers facing more pressure on their own finances and as such luxury drinks are one of the first casualties of the household budget. This is particularly so in regions such as Latin America, where income is generally lower and there are cheaper, local alternatives on offer.”

Despite the challenges, Diageo maintained or grew its market share in over 75% of its measured markets, including the crucial US market. The company also demonstrated financial resilience, with net cash flow from operating activities increasing by $0.5 billion to $4.1 billion and free cash flow rising by $0.4 billion to $2.6 billion.

In a show of confidence, Diageo increased its recommended full-year dividend by 5% to 103.48 cents per share.

Greggs’ mango iced drinks prove popular as menu innovation drives like-for-like sales

There’s no stopping Greggs and its array of reasonably priced baked goods, sandwiches and other on-the-go foods. 

Apart from the pandemic, Greggs’s sales growth has been consistently strong over the past decade, and the first half of 2024 was no exception.

Total first-half sales were 13.8% higher, driven by a combination of like-for-like same-store sales growth and the impact of 51 net new store openings.

Greggs shares were 3.80% higher at the time of writing.

The firm’s underlying pre-tax profit, excluding exceptional items, rose by 16.3% to £74.1 million. Underlying diluted earnings per share also showed a marked improvement, rising to 53.8p from 46.8p in the previous year.

“Greggs has showcased its strengths once more, as the UK’s favourite baker continues to deliver. A high bar’s been set over the past year or so, but results have beat expectations once again,” said Matt Britzman, senior equity analyst at Hargreaves Lansdown.

“The value offering that Greggs is so well known for has been holding it in good stead of late, and it was good to see that continue over the half with like-for-like sales well ahead of the industry average.”

In today’s update, Greggs pointed to menu innovation as a force for good when it came to boosting like-for-like sales. The roll out of mango and strawberry iced drinks across 500 stores and pizza meal deals spearheaded same store growth.

Greggs’ commitment to shareholder returns was evident in its announced interim dividend of 19.0 pence per share, representing an 18.8% increase from the previous year.

Looking to future effencies across the business, Greggs is making significant investments in its supply chain to support future growth. The redevelopment of its Birmingham distribution centre and the extension of its Amesbury facility are on track for completion in the second half of 2024. These improvements will create logistics capacity for an additional 300 shops. Furthermore, the company has begun construction of a new frozen manufacturing and logistics site in Derby, expected to be operational by late 2026.

BP profit grows as fuel margins increase, dividend increases 10%

Energy giant BP has increased its quarterly dividend by 10% and committed to additional share buybacks in the second half of the year.

Shareholder distributions will be in focus after profit growth grew marginally and cash generation jumped compared to the last quarter. BP has announced an underlying replacement cost (RC) profit of $2.8 billion for the second quarter of 2024, a slight increase from $2.7 billion in the previous quarter.

Stronger downstream fuel margins and lower taxation bolstered the company’s profitability amid lower oil prices. Although BP had areas of strength, gains were partially offset by significantly lower realised refining margins and an average gas marketing and trading result.

BP, like many other oil majors, has been through a period of adjustment as energy prices normalised after a prolonged elevation due to Russia’s invasion of Ukraine.

In the gas and low-carbon energy segment, BP reported an underlying RC profit before interest and tax of $1.4 billion. This represents a decrease from the previous quarter’s $1.7 billion, primarily due to average gas marketing and trading results. The absence of foreign exchange losses from the Egyptian pound devaluation and lower exploration write-offs partially mitigated this decline.

Oil production and operations maintained steady performance, with an underlying RC profit before interest and tax of $3.1 billion. Higher realisations were balanced by increased exploration write-offs, resulting in a figure identical to the previous quarter.

The customers and products segment saw mixed results. While the customers division improved by $0.4 billion due to stronger fuels margins and improved convenience store performance, the products division declined by $0.6 billion. This drop was attributed to significantly lower refining margins, particularly in middle distillates, and narrower North American heavy crude oil differentials.

Despite the underlying profit, BP reported a $0.1 billion loss for the quarter on a net basis. This was due to inventory holding losses and significant adjusting items, including a $1.5 billion charge related to asset impairments and onerous contract provisions. The ongoing review of the Gelsenkirchen refinery contributed to these adjustments.

“We generated strong operating cash flow* in the quarter, which helped reduce net debt* to $22.6 billion,” said Kate Thomson, BP’s CFO.

“Our decision to increase our dividend by 10%, and extend our buyback programme commitment to 4Q 2024, reflects the confidence we have in our performance and outlook for cash generation. We are maintaining a disciplined financial frame and remain committed to growing value and returns for bp.”

FTSE 100 gains ahead of Bank of England decision, Reckitts and Entain drag

UK equity bulls were out in force on Monday as markets geared up for a busy week of central bank action, with the Bank of England and Federal Reserve both deciding on interest rates this week.

The two are expected to keep rates on hold, although there is plenty of scope for a surprise interest rate cut, and markets are positioning for such an event. In any case, even if there isn’t a rate cut this week, the accompanying commentaries to the rates decisions are likley to hint very heavily at a rate cut.

Interest rate optimism helped the FTSE 100 rise on Monday. At the time of writing, the index was trading 0.85% higher at 8,355.

“UK markets open higher after avoiding too much backlash from last week’s tech selloff over the pond,” said Matt Britzman, senior equity analyst at Hargreaves Lansdown.

“Thursday’s Bank of England meeting could be the start of the journey to lower rates for the UK. Markets are unsure, pricing in around a 55% chance of a cut. If we do get cuts, sectors that have been under pressure in a higher-rate world, like infrastructure and real estate, could be due for a bump.”

Oil majors were in good form as energy prices rose, with Shell and BP adding a significant number of points to the index.

“Energy producers gave the FTSE 100 a welcome boost at the start of the new trading week,” said Dan Coatsworth, investment analyst at AJ Bell.

“Shell and BP were among the biggest contributors to the index’s performance as oil prices nudged higher to $81.21 per barrel. Oil prices had been on a downward trend since early July, so finding price stability has offered some reassurance.

“Shell and BP will update the market this week, and both have already got bad news out of the way with recent earnings previews that detailed multi-billion-dollar write-downs.”

Entain and Reckitt Benckiser

Although the index was firmly higher on Monday, there were two major drags on the index in Reckitt Benckiser and Entain.

“Shares in Reckitt are down around 9% this morning after news that a key rival in the US baby formula market has been fined $495mn by a US jury,” Matt Britzman said.

“Mead Johnson, a Reckitt subsidiary, is under threat of similar litigation. Reckitt has put the business on the chopping block as part of a recently announced strategy shift, which seems like a smart move. Reckitt has maintained stalwart support for innocence, but while Mead Johnson remains part of the group, developments in these cases will continue to have a significant impact on Reckitt’s performance.”

Entain was down 9.5% after announcing trading conditions for its BetMGM joint venture. Although US-focused betting services revenue grew, it signalled an increase in the competitive environment.

Adsure Services profits soar amid Generative AI LLM development, hikes dividend

Adsure Services announced a bumper increase in EBITDA and profit before tax for the full-year period ended 31st March after the internal audit and business assurance firm grew revenues and took action to control costs.

However, the most interesting element of today’s announcement for many investors may not be the 72% increase in profit before tax, but the update the company gave on the development of a Generative AI Large Language Model designed to enhance efficiencies for government-funded organisations.

Commenting on the AQUIS-listed company’s push to improve its technical capabilities in an effort to create operational efficiencies for its clients, Kevin Limn, CEO of Adsure Services, said:

“As part of our drive to improve efficiencies across the business, we have deployed an Innovate UK grant to develop proprietary Generative AI Large Language Model (LLM) technology specifically designed to enhance outcomes for our customers across government-funded organisations, including housing associations, healthcare services, emergency services, local governments and education institutions.”

Through its operating subsidiary, TIAA Ltd, Adsure Services provides government-funded organisations with a broad range of auditing and assurance services covering cyber security, HR, carbon emissions, IT systems, security management, and anti-crime.

Although Adsure is yet to release specific details about how the company will utilise an Innovate UK grant to help launch a Large Language Model, the successful implementation of such a service is likley to provide an additional source of growth for the company in the exciting world of Generative AI.

Indeed, in the full-year results released today, Adsure outlined a growth strategy with three core streams: ‘Organic growth in core markets, Accessing new markets for its existing range of services and Creating new technologies to revolutionise business assurance.’

Shareholders will eagerly await updates on the progress of the new technology.

Strong EBITDA and Profit before Tax growth

Beyond the group’s artificial intelligence developments, Adsure Services produced very respectable levels of growth in 2024FY. Revenue grew to £9.1m in the year to 31st March while profit before tax soared 72%.

“I’m delighted to report another year of growth for Adsure Services and TIAA Ltd,” said Vicky Davies, CFO of Adsure Services.

“Revenue for 2024 grew 3.4% to £9.3m (2023FY: £8.99m) and profit before taxation increased 72% to £471k (2023FY: £274k). Demonstrating action in cost control, our EBITDA margin improved to 9.4% (2023FY:7.31%).

“We have started the year strongly and will maintain our prudent approach to managing costs.”

The company has proposed a final dividend of 0.99p which will be paid later this year to add to the maiden interim dividend of 0.49p paid in April.

Despite only listing in London at the end of last year, the combination of the interim and final dividend infers a 5% dividend yield for the company.

Adsure generates recurring revenues from long-term contracts, which evidently provides the company with the confidence to pay dividends while pursuing a broad growth strategy.

“Our outlook is promising, and we have excellent visibility over our revenue in the years to come due to the long-term nature of our contracts, which deliver us recurring revenues,” Kevin Limn said.

S&P 500 weekly technical outlook 29th July

We had been nervous for a few weeks over the possibility of a profit taking snap emerging. So the recent minor sell-off has come as no major surprise.

We can see how price action has “only” dropped down to the lower end of the existing bullish trend channels. So little technical damage has been done on this move, so far.

In order to turn more nervous we would need to see price further into the older bullish trading range, blue region, currently under 5450. Buyers have already been tempted in, on the recent selling, on the hopes that the “buy on dips” strategy that has proved so profitable for so many months now will be good for at least one more leg higher.

However there are some very early signs that this buying may be more retail based buying, and less institutional, raising concerns around the Hindenburg Omen we highlighted a few weeks ago.

So for the week ahead this follow through buying may come through with enough scale on the key names that it could lift the wider market back above 5,600. But concerns remain for Q3 ahead and into Q4 as the record breaking run of the inverted US yielded curve continues and we have so much geopolitical uncertainty around the US election and possible international flash points in Ukraine/Russia, Israel/Gaza/Lebanon, China/Taiwan but that until/unless we see price action consolidate under the 5,400 area we remain in a strong bullish trend.

AIM movers: Quartix Technologies upgrade, but rival telematics firm Trakm8 hit by weak insurance income

3

UK Oil and Gas (LON: UKOG) shares continue to rebound following last week’s repayment of the convertible loan facility provided by RiverFort Global Opportunities and YA II PN. This means that there is no debt. The share price jumped a further 226.8% to 0.0915p. It is 542% higher than five days ago.

Mkango Resources (LON: MKA) has signed a writing agreement with the Malawi government for the Songwe Hill recycling project. There will be a royalty of 5% of gross revenues and a 30% corporate tax rate. The government will take a 10% non-diluting stake. The share price increased 47.8% to 6.8p.

Telematics services provider Quartix Technologies (LON: QTX) improved interim revenues by 10% to £16.1m and this has led to upgrades. Annualised recurring revenues are £30.9m. The interim dividend is 1.5p/share. Cavendish expects full year revenues to increase from £29.9m to £32.9m and pre-tax profit should improve from £5.1m to £5.5m. The share price is 13.1% higher at 181p.  

Schurter AG has a 4.69% stake in supercapacitors developer Cap-XX (LON: CPX). The share price improved 11.5% to 0.3625p.           

E-commerce company Huddled Group (LON: HUD) expects interim revenues will be at least £5.2m. There was £3.3m in cash at the end of June 2024 and cash is still flowing out of the business as marketing is scaled up. Discount Dragon, which sells surplus consumer goods, is generating £1m in revenues each month and it is trialling TV and radio investments. Warehouse capacity will be doubled next year. Operating divisions could be profitable on a monthly basis by the end of this year. The share price rose 7.02% to 3.05p.

FALLERS

Following recent management changes, Nostra Terra Oil and Gas (LON: NTOG) has raised £450,000 at 0.03p/share. The share price slid 59.4% to 0.0335p. Directors and management bought shares. This will be investing in a workover and development programme at the Pine Mills producing asset.

Telematics supplier Trakm8 (LON: TRAK) has been hampered by weak insurance market revenues and the recovery is slower than anticipated. Full year revenues fell from £20.2m to £16.1m, while recurring revenues edged down from £10.5m to £10.1m. The company moved into loss. Net debt was £4.9m at the end of March 2024. The share price dipped 11.8% to 7.5p.

The Nigel Williamson Family Trust has cut its stake in Clean Power Hydrogen (LON: CPH2) from 5.01% to 4.07%. The share price fell 7.32% to 9.5p.

Oil and gas producer Jadestone Energy (LON: JSE) increased production by 37% to 16,867 barrels of oil equivalent/day. Costs were kept flat. The annual production guidance has been increased from 20,000-22,000boe/day to 18,500-21,000boe/day because of delays in the start of production at Akatara. Net debt increased to $72.7m after the purchase of a 33.3% stake in CWLH2. The share price slipped 4.62% to 31p.